Conway Robert E's Form 4/A amendment
AmendedAlpine Immune Sciences, Inc. (ALPN) · filed Sep 27, 2021
- Accession no.
- 0001626199-21-000130
- Filed
- Sep 27, 2021
- Trade date
- Sep 23, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 24, 2021
This filing lists 1 non-derivative transaction. Open-market purchases total $151.2K. It was filed 4 days after the trade.
This amendment replaces 0001626199-21-000127 (filed Sep 24, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Conway Robert ECIK 0001184334 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Common Stock | PPurchaseAcquired | +15,000 | $10.08F2 | +$151,200 | 50,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Form 4 filed on September 24, 2021 inadvertently included an incorrect transaction code for the reported transaction. The transaction code included on the original Form 4 was "S" while the correct transaction code should have been "P".
- F2
This transaction was executed in multiple trades at prices ranging from $9.945 to $10.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.